IL6 and congenital rubella syndrome: Xue et al. still observed grade 3 CRS in 4 out of 18 patients treated with the anti-IL-6/IL-1Ra expressing CAR-T cells, noting the necessity of further investigation into the involvement of other factors in CRS.